Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
“Our proprietary intranasal platform has the potential to enhance drug delivery bioavailability. We believe that intranasal delivery has the potential to improve patient outcomes by providing a ...
Building biotech excellence: the growth strategy behind NeOnc Technologies’ vision
Contributor Content In his years as Director of Surgical Neuro-Oncology at the University of Southern California (USC), Dr. Thomas Chen has witnessed countless innovations in the world of cancer ...
Sniffling and sneezing? The pollen is back!
As of publication, tree pollen is the main culprit for allergies, and it’s in the high range. Even those trees that don’t ...
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update
FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)Assuming ...
Forget mouth taping to reduce snoring or sleep apnea symptoms — experts share 5 tips they'd use instead
"Dry throat tissues can increase snoring, so drinking enough water throughout the day should help combat this," he recommends ...
How you can plan ahead to prevent seasonal spring allergy symptoms
Spring officially starts March 20, but we're already in allergy season. Let's talk about the signs, symptoms, treatments, and ...
Dermatology Advisor4d
Neffy 1 mg Approved to Treat Severe Allergic Reactions in Younger Children
Neffy (epinephrine nasal spray) 1mg is approved for the emergency treatment of type 1 allergic reactions in children aged 4 ...
European Medical Journal5d
Nasal Spray Immunomodulation: A Novel Approach to Treating TBI
Nasal anti-CD3 spray reduces traumatic brain injury in mice, a potential breakthrough for TBI treatment. Read now.
The Brighterside of News on MSN5d
New nighttime nasal spray significantly alleviates sleep apnea
A nighttime nasal spray may offer a new way to ease sleep apnea and lower blood pressure, according to Australian researchers ...
California biotech company gets FDA approval for EpiPen alternative for kids
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients (March 5)
Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 ...
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...